An bhfuil gearán agat in aghaidh institiúid nó comhlacht de chuid an Aontais Eorpaigh?
- EN English
Follow-up reply of the European Ombudsman in response to the European Medicines Agency (EMA)on how it deals with requests for public access to documents (Case 2243/2022/SF)
Comhfhreagras - Dáta Dé Máirt | 29 Aibreán 2025
Cás 2243/2022/SF - Tosaithe an Dé Máirt | 14 Feabhra 2023 - Cinneadh an Dé Céadaoin | 13 Nollaig 2023 - Institiúid ábhartha An Ghníomhaireacht Leigheasra Eorpach ( Cásanna inar aimsíodh míriarachán ) - Tír An Ísiltír
Tá an gearán déanta
13/12/2022Anailís ar an ngearán
13/12/2022Fiosrúchán ar siúl
11/01/2023Toradh an fhiosrúcháin
13/12/2023
|
Head of Legal Department European Medicines Agency |
Dear Mr X,
We thank you for EMA’s reply to the Ombudsman’s suggestions for improvement in the above case.
We welcome EMA’s continuous efforts to identify documents, which are of particular interest to the public and which could possibly be published proactively. We have taken note of the measures EMA has taken to phase out its chronological queue and to deal with the backlog of public access requests. We are pleased to see that these measures have already led to a decrease in the backlog.
We also note that EMA acknowledges the Ombudsman’s finding of maladministration with regard to the ‘5-2-rule’, whereby EMA limits the number of requests per applicant to five at a given time and the number of documents that can be requested at a time to two documents. However, EMA has not committed to cease applying that practice. We will therefore continue to monitor EMA’s implementation of Regulation 1049/2001 to determine whether the Ombudsman needs to pursue this matter on her own initiative.
Yours sincerely,
Rosita Hickey
Director of Inquiries
Strasbourg, 12/07/2024